Actively Recruiting
Study of Thyroid Dysfunction in Adults with Metabolic Dysfunction-Associated Fatty Liver Disease Observational Study Using Fibroscan Device
Led by Tanta University · Updated on 2024-12-20
150
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Metabolic dysfunction-associated fatty liver disease MAFLD is a common cause of chronic liver disease affecting about 30% of adults. This research investigates how thyroid dysfunction relates to MAFLD, as thyroid hormones play a key role in maintaining metabolism and liver health. The study explores the potential link between thyroid disorders and liver disease progression. Participants include patients with MAFLD and healthy controls. The study uses a device called Fibroscan, which applies ultrasound technology to assess liver fibrosis and fat accumulation by measuring the speed of elastic shear waves through the liver. This allows researchers to evaluate liver condition non-invasively. During the study, blood samples will be collected to measure levels of free triiodothyronine FT3, free thyroxine FT4, and thyroid-stimulating hormone. The relationship between thyroid function, metabolic data, and gender will also be examined. Participants will undergo Fibroscan assessments to determine liver status. The study aims to better understand how thyroid health affects MAFLD and involves adults aged 18 and older.
CONDITIONS
Brief Title
Thyroid Dysfunction and Its Association With Metabolic Dysfunction-Associated Fatty Liver Disease
Research Team
S
Shimaa A Meshaal, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
